MARSHALL & POPP, LLC for JAZZ PHARMACEUTICALS, INC. AND ITS SUBSIDIARIES, INCLUDING GREENWICH BIOSCIENCES
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Banking BAN
Issues related to the definition of "business of insurance". H.R.1595: Secure And Fair Enforcement Banking Act of 2019. H.R.6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act. S.4775: Delivering Immediate Relief to America's Families, Schools and Small Businesses Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HAZEN CLAY MARSHALL | — |
| MONICA POPP | — |
Health Issues HCR
Issues related to the Food and Drug Administration. Issues related to the COVID-19 pandemic. Issues related to the cannabis research: S.2032: Cannabidiol and Marihuana Research Expansion Act. H.R.3797: Medical Marijuana Research Act. H.R.7614: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021. H.R.3884: MORE Act of 2020. H.R.133 [116TH]: Consolidated Appropriations Act, 2021.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HAZEN CLAY MARSHALL | Policy Director-Senate Majority Leader Mitch McConnell; Staff Director/Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don Nickles |
| MONICA POPP | Chief of Staff/Deputy Chief of Staff, Office of Senate Republican Whip John Cornyn; Professional Staff Member, U.S. House of Representatives-Energy & Commerce Committee; Legislative Assistant, Senator Jim DeMint |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.